Recombinant Mouse DLL1 Fc Chimera Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 5026-DL
Key Product Details
Source
Accession #
Structure / Form
Conjugate
Applications
Product Specifications
Source
Mouse DLL1 (Ser22-Gln516) Accession # Q61483 |
LIEGRMDP | Mouse IgG2A (Glu98-Lys330) |
N-terminus | C-terminus |
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for this effect is 0.25-1 μg/mL.
Reviewed Applications
Read 2 reviews rated 4.5 using 5026-DL in the following applications:
Formulation, Preparation and Storage
5026-DL
Formulation | Lyophilized from a 0.2 μm filtered solution in HEPES and EDTA. |
Reconstitution |
Reconstitute at 500 μg/mL in sterile PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: DLL1
Delta-like protein 1 (DLL1) is a 90-100 kDa type I transmembrane protein in the Delta/Serrate/Lag-2 (DSL) family of Notch ligands. Mature mouse DLL1 consists of a 528 amino acid (aa) extracellular domain (ECD) with one DSL domain and eight EGF-like repeats, a 23 aa transmembrane segment, and a 154 aa cytoplasmic domain (1). Within the ECD, mouse DLL1 shares 91% and 95% aa sequence identity with human and rat DLL1, respectively. It shares 26%, 35%, and 51% aa sequence identity with DLL2, 3, and 4, respectively. A 60 kDa ECD fragment, released by ADAM9, 12, or 17 mediated proteolysis, promotes the proliferation of hematopoietic progenitor cells (2, 3). The residual membrane-bound portion of DLL1 can be cleaved by presenilin-dependent gamma-secretase, enabling the cytoplasmic domain to migrate to the nucleus (4). DLL1 localizes to adherens junctions on neuronal processes through its association with the scaffolding protein MAGI1 (5). DLL1 is widely expressed, and it plays an important role in embryonic somite formation, cochlear hair cell differentiation, lymphocyte differentiation, and the maintenance of neural and myogenic progenitor cells (6-12). The up-regulation of DLL1 in arterial endothelial cells following injury or angiogenic stimulation is central to postnatal arteriogenesis (13). DLL1 is also over-expressed in cervical carcinoma and glioma and contributes to tumor progression (14, 15).
References
- Bettenhausen, B. et al. (1995) Development 121:2407.
- Dyczynska, E. et al. (2007) J. Biol. Chem. 282:436.
- Karanu, F.N. et al. (2001) Blood 97:1960.
- Ikeuchi, T. and S.S. Sisodia (2003) J. Biol. Chem. 278:7751.
- Mizuhara, E. et al. (2005) J. Biol. Chem. 280:26499.
- Takahashi, Y. et al. (2003) Development 130:4259.
- Teppner, I. et al. (2007) BMC Dev. Biol. 7:68.
- Kiernan, A.E. et al. (2005) Development 132:4353.
- Schmitt, T.M. and J.C. Zuniga-Pflucker (2002) Immunity 17:749.
- Hozumi, K. et al. (2004) Nat. Immunol. 5:638.
- Shimojo, H. et al. (2008) Neuron 58:52.
- Schuster-Gossler, K. et al. (2007) Proc. Natl. Acad. Sci. 104:537.
- Limbourg, A. et al. (2007) Circ. Res. 100:363.
- Purow, B.W. et al. (2005) Cancer Res. 65:2353.
- Gray, G.E. et al. (1999) Am. J. Pathol. 154:785.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional DLL1 Products
Product Documents for Recombinant Mouse DLL1 Fc Chimera Protein, CF
Product Specific Notices for Recombinant Mouse DLL1 Fc Chimera Protein, CF
For research use only